                         SEQUENCE LISTING

<110>  F.Hoffmann-La Roche Ldt
 
<120>  Peptides

<130>  P32452-WO

<150>  EP15178162.2
<151>  2015-07-24

<160>  71    

<170>  PatentIn version 3.5

<210>  1
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified peptide


<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  X=PEG(4)

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Z=Sta

<220>
<221>  VARIANT
<222>  (16)..(16)
<223>  DPro

<400>  1

Tyr Pro Tyr Phe Ile Pro Leu Xaa Glu Val Asn Glx Val Ala Glu Pro 
1               5                   10                  15      


<210>  2
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified peptide


<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  Z=Statine

<220>
<221>  VARIANT
<222>  (18)..(18)
<223>  DPro

<400>  2

Tyr Pro Tyr Phe Ile Pro Leu Gly Gly Gly Glu Val Asn Glx Val Ala 
1               5                   10                  15      


Glu Pro 
        


<210>  3
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified peptide


<220>
<221>  VARIANT
<222>  (9)..(9)
<223>  DLys

<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  Z=Statine

<220>
<221>  VARIANT
<222>  (18)..(18)
<223>  DPro

<400>  3

Tyr Pro Tyr Phe Ile Pro Leu Gly Lys Gly Glu Val Asn Glx Val Ala 
1               5                   10                  15      


Glu Pro 
        


<210>  4
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified peptide


<220>
<221>  VARIANT
<222>  (9)..(9)
<223>  DLys

<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  Z=Statine

<220>
<221>  VARIANT
<222>  (18)..(18)
<223>  DPro

<400>  4

Tyr Pro Lys Phe Ile Pro Leu Gly Lys Gly Glu Val Asn Glx Val Ala 
1               5                   10                  15      


Glu Pro 
        


<210>  5
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified peptide


<220>
<221>  VARIANT
<222>  (7)..(7)
<223>  DLys

<220>
<221>  VARIANT
<222>  (9)..(9)
<223>  DLys

<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  Z=Statine

<220>
<221>  VARIANT
<222>  (18)..(18)
<223>  DPro

<400>  5

Tyr Pro Tyr Phe Ile Pro Lys Gly Lys Gly Glu Val Asn Glx Val Ala 
1               5                   10                  15      


Glu Pro 
        


<210>  6
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified peptide


<220>
<221>  VARIANT
<222>  (9)..(9)
<223>  DLys

<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  Z=Statine

<220>
<221>  VARIANT
<222>  (18)..(18)
<223>  DPro

<400>  6

Tyr Pro Tyr Phe Lys Pro Ala Gly Lys Gly Glu Val Asn Glx Val Ala 
1               5                   10                  15      


Glu Pro 
        


<210>  7
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified peptide


<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  X=PEG(4)

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Z=MetStatine

<220>
<221>  VARIANT
<222>  (16)..(16)
<223>  DPhe

<400>  7

Tyr Pro Tyr Phe Ile Pro Leu Xaa Glu Val Asn Glx Val Ala Glu Phe 
1               5                   10                  15      


<210>  8
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified peptide


<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  X=PEG(4)

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Y=MetStatine

<220>
<221>  VARIANT
<222>  (12)..(12)

<400>  8

Tyr Pro Tyr Phe Ile Pro Leu Xaa Glu Val Asn Tyr Val Ala Glu Pro 
1               5                   10                  15      


<210>  9
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified peptide


<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  Z=MetStatine

<400>  9

Tyr Pro Tyr Phe Ile Pro Leu Gly Gly Gly Glu Val Asn Glx Val Ala 
1               5                   10                  15      


Glu Pro 
        


<210>  10
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified peptide


<220>
<221>  VARIANT
<222>  (9)..(9)
<223>  DLys

<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  Z=MetStatine

<400>  10

Tyr Pro Tyr Phe Ile Pro Leu Gly Lys Gly Glu Val Asn Glx Val Ala 
1               5                   10                  15      


Glu Pro 
        


<210>  11
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified peptide


<220>
<221>  VARIANT
<222>  (9)..(9)
<223>  DLys

<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  Z=MetStatine

<400>  11

Tyr Pro Lys Phe Ile Pro Leu Gly Lys Gly Glu Val Asn Glx Val Ala 
1               5                   10                  15      


Glu Pro 
        


<210>  12
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified peptide


<220>
<221>  VARIANT
<222>  (6)..(6)
<223>  DLys

<220>
<221>  VARIANT
<222>  (9)..(9)
<223>  DLys

<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  Z=Statine

<220>
<221>  VARIANT
<222>  (18)..(18)
<223>  DPro

<400>  12

Tyr Pro Tyr Phe Ile Lys Leu Gly Lys Gly Glu Val Asn Glx Val Ala 
1               5                   10                  15      


Glu Pro 
        


<210>  13
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified peptide


<220>
<221>  VARIANT
<222>  (5)..(5)
<223>  D-Lys

<220>
<221>  VARIANT
<222>  (9)..(9)
<223>  D-Lys

<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  Z=Statine

<220>
<221>  VARIANT
<222>  (18)..(18)
<223>  DPro

<400>  13

Tyr Pro Tyr Phe Lys Pro Leu Gly Lys Gly Glu Val Asn Glx Val Ala 
1               5                   10                  15      


Glu Pro 
        


<210>  14
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified peptide


<220>
<221>  VARIANT
<222>  (9)..(9)
<223>  DLys

<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  Z=Statine

<220>
<221>  VARIANT
<222>  (18)..(18)
<223>  DPro

<400>  14

Tyr Pro Tyr Phe Lys Pro Ala Gly Lys Gly Glu Val Asn Glx Val Ala 
1               5                   10                  15      


Glu Pro 
        


<210>  15
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified peptide


<220>
<221>  VARIANT
<222>  (9)..(9)
<223>  DLys

<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  Z=Statine

<220>
<221>  VARIANT
<222>  (18)..(18)
<223>  DPro

<400>  15

Thr Pro Lys Pro Ala Gln Gly Gly Lys Gly Glu Val Asn Glx Val Ala 
1               5                   10                  15      


Glu Pro 
        


<210>  16
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified peptide


<220>
<221>  VARIANT
<222>  (9)..(9)
<223>  DLys

<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  Z=Statine

<220>
<221>  VARIANT
<222>  (18)..(18)
<223>  DPro

<400>  16

Gly Ala Arg Phe Ile Pro Ala Gly Lys Gly Glu Val Asn Glx Val Ala 
1               5                   10                  15      


Glu Pro 
        


<210>  17
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified peptide


<220>
<221>  VARIANT
<222>  (9)..(9)
<223>  DLys

<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  Y=Statine

<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  Z=Statine

<220>
<221>  VARIANT
<222>  (18)..(18)
<223>  DPro

<400>  17

Tyr Pro Lys Phe Ile Ser Ala Gly Lys Gly Glu Val Asn Glx Val Ala 
1               5                   10                  15      


Glu Pro 
        


<210>  18
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified peptide


<220>
<221>  VARIANT
<222>  (7)..(7)
<223>  DLys

<220>
<221>  VARIANT
<222>  (9)..(9)
<223>  DLys

<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  Z=MetStatine

<400>  18

Tyr Pro Tyr Phe Ile Pro Lys Gly Lys Gly Glu Val Asn Glx Val Ala 
1               5                   10                  15      


Glu Pro 
        


<210>  19
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified peptide


<220>
<221>  VARIANT
<222>  (7)..(7)
<223>  DLys

<220>
<221>  VARIANT
<222>  (9)..(9)
<223>  DLys

<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  Z=MetStatine

<220>
<221>  VARIANT
<222>  (18)..(18)
<223>  DPhe

<400>  19

Tyr Pro Tyr Phe Ile Pro Lys Gly Lys Gly Glu Val Asn Glx Val Ala 
1               5                   10                  15      


Glu Phe 
        


<210>  20
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified peptide


<220>
<221>  VARIANT
<222>  (1)..(1)
<223>  DLys

<220>
<221>  VARIANT
<222>  (9)..(9)
<223>  DLys

<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  z=Statine

<220>
<221>  VARIANT
<222>  (18)..(18)
<223>  DPro

<400>  20

Lys Pro Tyr Phe Ile Pro Leu Gly Lys Gly Glu Val Asn Glx Val Ala 
1               5                   10                  15      


Glu Pro 
        


<210>  21
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified peptide


<220>
<221>  VARIANT
<222>  (1)..(1)
<223>  1 H-Tyr

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  X=PEG(4)

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  z=Statine

<220>
<221>  VARIANT
<222>  (16)..(16)
<223>  DPro

<400>  21

Tyr Pro Lys Phe Ile Pro Leu Xaa Glu Val Asn Glx Val Ala Glu Pro 
1               5                   10                  15      


<210>  22
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified peptide


<220>
<221>  VARIANT
<222>  (1)..(1)
<223>  H-Tyr

<220>
<221>  VARIANT
<222>  (7)..(7)
<223>  DLys

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  X=PEG(4)

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Z=Statine

<220>
<221>  VARIANT
<222>  (16)..(16)
<223>  DPro

<400>  22

Tyr Pro Tyr Phe Ile Pro Lys Xaa Glu Val Asn Glx Val Ala Glu Pro 
1               5                   10                  15      


<210>  23
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified peptide


<220>
<221>  VARIANT
<222>  (1)..(1)
<223>  H-Tyr

<220>
<221>  VARIANT
<222>  (5)..(5)
<223>  DLys

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  X=PEG(4)

<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  Z=Statine

<220>
<221>  VARIANT
<222>  (15)..(15)
<223>  DPro

<400>  23

Tyr Pro Tyr Phe Lys Leu Xaa Glu Val Asn Glx Val Ala Glu Pro 
1               5                   10                  15  


<210>  24
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified peptide


<220>
<221>  VARIANT
<222>  (1)..(1)
<223>  H-Tyr

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  X=PEG(4)

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Z=Statine

<220>
<221>  VARIANT
<222>  (16)..(16)
<223>  DPro

<400>  24

Tyr Pro Tyr Phe Lys Pro Leu Xaa Glu Val Asn Glx Val Ala Glu Pro 
1               5                   10                  15      


<210>  25
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified peptide


<220>
<221>  VARIANT
<222>  (7)..(7)
<223>  DLys

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  X=PEG(4)

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Y=LEU*ALA

<220>
<221>  VARIANT
<222>  (15)..(15)
<223>  DPro

<400>  25

Tyr Pro Tyr Phe Ile Pro Lys Xaa Glu Val Asn Tyr Ala Glu Pro 
1               5                   10                  15  


<210>  26
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified peptide


<220>
<221>  VARIANT
<222>  (5)..(5)
<223>  DLys

<220>
<221>  VARIANT
<222>  (8)..(8)
<223>  DLys

<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  Z=LEU*ALA

<220>
<221>  VARIANT
<222>  (16)..(16)
<223>  DPro

<400>  26

Tyr Pro Tyr Phe Lys Leu Gly Lys Gly Glu Val Asn Glx Ala Glu Pro 
1               5                   10                  15      


<210>  27
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified peptide


<220>
<221>  VARIANT
<222>  (7)..(7)
<223>  DLys

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  X=PEG(4)

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Z=MetStatine

<220>
<221>  VARIANT
<222>  (16)..(16)
<223>  DPro

<400>  27

Tyr Pro Tyr Phe Ile Pro Lys Xaa Glu Val Asn Glx Val Ala Glu Pro 
1               5                   10                  15      


<210>  28
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified peptide


<220>
<221>  VARIANT
<222>  (1)..(1)
<223>  H-DTyr

<220>
<221>  VARIANT
<222>  (7)..(7)
<223>  DLys

<220>
<221>  VARIANT
<222>  (9)..(9)
<223>  DLys

<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  Z=Statine

<220>
<221>  VARIANT
<222>  (18)..(18)
<223>  DPro

<400>  28

Tyr Pro Tyr Phe Ile Pro Lys Gly Lys Gly Glu Val Asn Glx Val Ala 
1               5                   10                  15      


Glu Pro 
        


<210>  29
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified peptide


<220>
<221>  VARIANT
<222>  (1)..(1)
<223>  H-DTyr

<220>
<221>  VARIANT
<222>  (9)..(9)
<223>  DLys

<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  Z=Statine

<220>
<221>  VARIANT
<222>  (18)..(18)
<223>  DPro

<400>  29

Tyr Pro Tyr Phe Ile Pro Leu Gly Lys Gly Glu Val Asn Glx Val Ala 
1               5                   10                  15      


Glu Pro 
        


<210>  30
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified peptide


<220>
<221>  VARIANT
<222>  (1)..(1)
<223>  Ac-DTyr

<220>
<221>  VARIANT
<222>  (9)..(9)
<223>  DLys

<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  Z=Statine

<220>
<221>  VARIANT
<222>  (18)..(18)
<223>  DPro

<400>  30

Ala Cys Tyr Pro Tyr Phe Ile Pro Leu Gly Lys Gly Glu Val Asn Glx 
1               5                   10                  15      


Val Ala Glu Pro 
            20  


<210>  31
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified peptide


<220>
<221>  VARIANT
<222>  (1)..(1)
<223>  Ac-Gln

<400>  31

Ala Cys Gln Gln Tyr Pro Tyr Phe Lys Pro Ala Asn 
1               5                   10          


<210>  32
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified peptide


<220>
<221>  VARIANT
<222>  (1)..(1)
<223>  Ac-Tyr

<400>  32

Ala Cys Tyr Pro Thr Phe Lys Pro Ala Asn Gly Ser 
1               5                   10          


<210>  33
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified peptide


<220>
<221>  VARIANT
<222>  (1)..(1)
<223>  Ac-Ser

<400>  33

Ala Cys Ser Thr Gly Ala Arg Phe Ile Pro Ala Asn 
1               5                   10          


<210>  34
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified peptide


<220>
<221>  VARIANT
<222>  (1)..(1)
<223>  Ac-Gly

<400>  34

Ala Cys Gly Asp Tyr Pro Lys Phe Ile Ser Ala Asn 
1               5                   10          


<210>  35
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified peptide


<220>
<221>  VARIANT
<222>  (1)..(1)
<223>  Ac-Gly

<400>  35

Ala Cys Gly Asp Tyr Pro Lys Phe Ile Pro Ala Ser 
1               5                   10          


<210>  36
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified peptide


<220>
<221>  VARIANT
<222>  (1)..(1)
<223>  Ac-Gly

<400>  36

Ala Cys Gly Ser Tyr Pro Lys Phe Ile Asp Ala Asn 
1               5                   10          


<210>  37
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified peptide


<220>
<221>  VARIANT
<222>  (1)..(1)
<223>  Ac-Leu

<400>  37

Ala Cys Leu Thr Thr Tyr Pro Tyr Phe Lys Pro Ala 
1               5                   10          


<210>  38
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified peptide


<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Z=Statine

<400>  38

Glu Val Asn Glx Val Ala Glu Phe 
1               5               


<210>  39
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified peptide


<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Z=Metstatine

<220>
<221>  VARIANT
<222>  (8)..(8)
<223>  DPhe

<400>  39

Glu Val Asn Glx Val Ala Glu Phe 
1               5               


<210>  40
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified peptide


<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Z=Statine

<220>
<221>  VARIANT
<222>  (8)..(8)
<223>  DPro

<400>  40

Glu Val Asn Glx Val Ala Glu Pro 
1               5               


<210>  41
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified peptide

<400>  41

Tyr Pro Tyr Phe Lys Pro Ala 
1               5           


<210>  42
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified peptide

<400>  42

Gln Tyr Pro Tyr Phe Lys Pro Ala 
1               5               


<210>  43
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified peptide

<400>  43

Tyr Pro Tyr Phe Lys Pro Ala Ser 
1               5               


<210>  44
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified peptide

<400>  44

Tyr Pro Thr Phe Lys Pro Ala 
1               5           


<210>  45
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified peptide

<400>  45

Asp Tyr Pro Lys Phe Ile Ser 
1               5           


<210>  46
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified peptide

<400>  46

Asp Tyr Pro Lys Phe Leu Pro 
1               5           


<210>  47
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified peptide

<400>  47

Ser Tyr Pro Lys Phe Ile Asp 
1               5           


<210>  48
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified peptide

<400>  48

Thr Gly Ala Arg Phe Ile Pro Ala Asn 
1               5                   


<210>  49
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified peptide

<400>  49

Gly Gln Tyr Pro Tyr Phe Lys Pro Ala Ser 
1               5                   10  


<210>  50
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified peptide

<400>  50

Gln Tyr Pro Tyr Phe Lys Pro Ala Ser Gly 
1               5                   10  


<210>  51
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified peptide

<400>  51

Gly Gly Gly Tyr Pro Thr Phe Lys Pro Ala 
1               5                   10  


<210>  52
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified peptide

<400>  52

Gly Gly Tyr Pro Thr Phe Lys Pro Ala Gly 
1               5                   10  


<210>  53
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified peptide

<400>  53

Gly Tyr Pro Thr Phe Lys Pro Ala Gly Gly 
1               5                   10  


<210>  54
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified peptide

<400>  54

Tyr Pro Thr Phe Lys Pro Ala Gly Gly Gly 
1               5                   10  


<210>  55
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified peptide

<400>  55

Gly Asp Tyr Pro Lys Phe Ile Ser Gly Gly 
1               5                   10  


<210>  56
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified peptide

<400>  56

Gly Asp Tyr Pro Lys Phe Leu Pro Gly Gly 
1               5                   10  


<210>  57
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified peptide

<400>  57

Gly Ser Tyr Pro Lys Phe Ile Asp Gly Gly 
1               5                   10  


<210>  58
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified peptide

<400>  58

Gly Thr Gly Ala Arg Phe Ile Pro Ala Asn 
1               5                   10  


<210>  59
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified peptide

<400>  59

Thr Gly Ala Arg Phe Ile Pro Ala Asn Gly 
1               5                   10  


<210>  60
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified peptide

<400>  60

Gln Gln Tyr Pro Tyr Phe Lys Pro Ala Asn 
1               5                   10  


<210>  61
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified peptide

<400>  61

Tyr Pro Thr Phe Lys Pro Ala Asn Gly Ser 
1               5                   10  


<210>  62
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified peptide

<400>  62

Gly Asp Tyr Pro Lys Phe Ile Ser Ala Asn 
1               5                   10  


<210>  63
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified peptide

<400>  63

Gly Asp Tyr Pro Lys Phe Ile Pro Ala Ser 
1               5                   10  


<210>  64
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified peptide

<400>  64

Gly Ser Tyr Pro Lys Phe Ile Asp Ala Asn 
1               5                   10  


<210>  65
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified peptide

<400>  65

Ser Thr Gly Ala Arg Phe Ile Pro Ala Asn 
1               5                   10  


<210>  66
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified peptide


<220>
<221>  VARIANT
<222>  (1)..(1)
<223>  H-Tyr

<220>
<221>  VARIANT
<222>  (2)..(2)
<223>  DLys

<220>
<221>  VARIANT
<222>  (9)..(9)
<223>  DLys

<220>
<221>  VARIANT
<222>  (18)..(18)
<223>  DPro

<220>
<221>  MISC_FEATURE
<222>  (18)..(18)
<223>  Z=Statine

<400>  66

Tyr Lys Tyr Phe Ile Pro Leu Gly Lys Gly Glu Val Asn Glx Val Ala 
1               5                   10                  15      


Glu Pro 
        


<210>  67
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified peptide


<220>
<221>  VARIANT
<222>  (1)..(1)
<223>  H-Tyr

<220>
<221>  VARIANT
<222>  (3)..(3)
<223>  DLys

<220>
<221>  VARIANT
<222>  (9)..(9)
<223>  DLys

<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  Z=Statine

<220>
<221>  VARIANT
<222>  (18)..(18)
<223>  DPro

<400>  67

Tyr Pro Lys Phe Ile Pro Leu Gly Lys Gly Glu Val Asn Glx Val Ala 
1               5                   10                  15      


Glu Pro 
        


<210>  68
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified peptide


<220>
<221>  VARIANT
<222>  (1)..(1)
<223>  H-Tyr

<220>
<221>  VARIANT
<222>  (4)..(4)
<223>  DLys

<220>
<221>  VARIANT
<222>  (9)..(9)
<223>  DLys

<220>
<221>  MISC_FEATURE
<222>  (14)..(14)

<220>
<221>  VARIANT
<222>  (18)..(18)
<223>  DPro

<400>  68

Tyr Pro Tyr Lys Ile Pro Leu Gly Lys Gly Glu Val Asn Glx Val Ala 
1               5                   10                  15      


Glu Pro 
        


<210>  69
<211>  22
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  B=Biotin

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  X=PEG2

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  X=PEG8

<220>
<221>  VARIANT
<222>  (11)..(11)
<223>  DLys

<220>
<221>  VARIANT
<222>  (13)..(13)
<223>  DLys

<220>
<221>  MISC_FEATURE
<222>  (18)..(18)
<223>  Z=Statine

<220>
<221>  VARIANT
<222>  (22)..(22)
<223>  DPro

<400>  69

Asx Xaa Cys Xaa Tyr Pro Tyr Phe Ile Pro Lys Gly Lys Gly Glu Val 
1               5                   10                  15      


Asn Glx Val Ala Glu Pro 
            20          


<210>  70
<211>  22
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  B=Biotin

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  X=PEG2

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  X=PEG3

<220>
<221>  VARIANT
<222>  (11)..(11)
<223>  DLys

<220>
<221>  VARIANT
<222>  (13)..(13)
<223>  DLys

<220>
<221>  MISC_FEATURE
<222>  (18)..(18)
<223>  Z=Sta

<220>
<221>  VARIANT
<222>  (22)..(22)
<223>  DPro

<400>  70

Asx Xaa Cys Xaa Tyr Pro Tyr Phe Ile Pro Lys Gly Lys Gly Glu Val 
1               5                   10                  15      


Asn Glx Val Ala Glu Pro 
            20          


<210>  71
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  modified peptide


<220>
<221>  VARIANT
<222>  (1)..(1)
<223>  H-Gly

<220>
<221>  VARIANT
<222>  (10)..(10)
<223>  DLys

<220>
<221>  VARIANT
<222>  (12)..(12)
<223>  DLys

<220>
<221>  MISC_FEATURE
<222>  (17)..(17)
<223>  Z=Statine

<220>
<221>  VARIANT
<222>  (21)..(21)
<223>  DPro

<400>  71

Gly Gly Gly Tyr Pro Tyr Phe Ile Pro Lys Gly Lys Gly Glu Val Asn 
1               5                   10                  15      


Glx Val Ala Glu Pro 
            20      


